Incyte Corporation

1801 Augustine Cut-off, Wilmington, DE 19803

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer.

Click to rate this company
[Total: 0 Average: 0]

3.9

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

The entirety of our Board of Directors oversees our ESG strategy—which includes targets and initiatives that aim to reduce our environmental impact. Board Committees are responsible for various elements of ESG; for example, our Audit Committee oversees risk management and the Compensation Committee oversees compensation-related goals and targets, as well as our progress against these targets. At the management level, each Incyte location takes responsibility for monitoring and driving down its emissions, water use and waste.Incyte supports our employees’ efforts to make a difference in their communities. Through our Community Service Program, we provide an annual day of paid time off for employees to volunteer with the charitable causes they’re passionate about. In 2022, employee participation in our Community Service Program benefited communities around the world, with 250 employees reporting more than 1,500 hours of volunteer service. To promote employee volunteering, one of our key 2023 ESG targets is for at least 15% of global employees to participate in community volunteer activities through the use of their paid employee volunteer day. Matching employees contributions to the causes that are most important to them helps foster a sense of community and amplifies our collective impact. Through the program, we match employee contributions to eligible nonprofits dollar for dollar, up to a predetermined cap. Based on employee feedback, in July of 2022 we doubled the pre-determined cap. This, coupled with increased employee participation, helps us to make an even more significant difference in our communities.Strong ethics and good governance are fundamental to our success and to building long-term value for our shareholders and a positive impact for our patients, colleagues, community and environment. Our Board of Directors sets high standards, guides our business strategy and, as our highest level of oversight, ensures that we practice good governance. We believe engaged directors with a diverse range of experience are vital components of strong oversight. The individuals who comprise our Board bring a depth of scientific knowledge, a range of industry expertise and a sense of integrity to our business. They’re successful, experienced individuals who understand our business and have the skills to facilitate long-term success.Incyte Charitable Giving Foundation is dedicated to making a difference where we live and work – specifically Wilmington, Delaware, home to our Global Headquarters. The Foundation forges partnerships with publicly funded 501(c) (3) tax-exempt nonprofit organizations who serve Delaware communities in two focus areas—Oncology Patient Support and Resources and Community Partnerships. In 2022, the Foundation’s combined donation of over $900,000 benefited more than 30 local causes—including those providing support, financial assistance and other valuable services to our community.At Incyte, we’re collectively responsible for delivering innovative solutions for our patients. This approach encourages collaboration across departments, allows leaders to emerge at all levels and ensures all colleagues feel valued. We know our strength lies in the collective expertise, experience, passion and perseverance of our diverse team. By creating a collaborative culture that integrates those insights and abilities, we’re advancing scientific innovation, improving the health of our patients and empowering our colleagues to contribute to their full potential.

Eligible Awards

Coming Soon




Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$3,300,000,000.00

Website Traffic

Employee Rating

4.1

Customer Rating

3.9

Company Size

1000-5000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.